Ranilonga en es it fr

Ranilonga Brand names, Ranilonga Analogs

Ranilonga Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ranilonga Chemical_Formula


Ranilonga RX_link


Ranilonga fda sheet

Ranilonga FDA

Ranilonga msds (material safety sheet)

Ranilonga MSDS

Ranilonga Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ranilonga Molecular Weight

314.405 g/mol

Ranilonga Melting Point

69-70 oC

Ranilonga H2O Solubility

24.7 mg/mL

Ranilonga State


Ranilonga LogP


Ranilonga Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ranilonga Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ranilonga Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ranilonga Absorption

Approximately 50% bioavailability orally.

Ranilonga side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ranilonga Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ranilonga Organisms Affected

Humans and other mammals